VMI
ONC

VHCP Management II’s BeOne Medicines Ltd ONC Stock Holding History

VHCP Management II’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-119,000
Closed -$3.67M – 25
2016
Q3 		$3.67M Hold
119,000
– – 1.88% 13
2016
Q2 		$3.55M Hold
119,000
– – 2.14% 14
2016
Q1 		$3.49M Buy
+119,000
New +$3.37M 2.29% 15

Other funds holding ONC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

VHCP Management II's ONC Position: Q4 2016 in Review

VHCP Management II sold out of BeOne Medicines Ltd (ONC) in Q4 2016, closing a stake of 119,000 shares — an estimated $3.67M sold.

VHCP Management II first reported a position in ONC in Q1 2016 and held it in 3 quarters. The position peaked at $3.67M in Q3 2016. 54 funds tracked by Wall St. Rank hold ONC as of Q4 2016.

  • VHCP Management II reported no remaining BeOne Medicines Ltd position as of Q4 2016 after selling out during the quarter.
  • VHCP Management II sold 119,000 BeOne Medicines Ltd shares in Q4 2016, an estimated $3.67M.
  • VHCP Management II first reported a position in BeOne Medicines Ltd in Q1 2016 and held it in 3 quarters.
  • VHCP Management II's BeOne Medicines Ltd position peaked at $3.67M in Q3 2016.
  • 54 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2016.

Based on VHCP Management II's 13F filing for Q4 2016, filed 13 Feb 2017.